Matt's Take By Matthew Herper The coronavirus exposes our health care system’s weaknesses. We can be stronger
Matt's Take By Matthew Herper Coronavirus testing is starting to get better — but it has a long way to go
Matt's Take By Matthew Herper The U.S. gets a D- in the coronavirus fight. That stands for ‘disorganization,’ and it’s fixable
Matt's Take By Matthew Herper The debate over America’s drug-pricing system is built on myths. It’s time to face reality
Biotech By Adam Feuerstein and Matthew Herper STAT’s guide to the most important, beneficial drugs approved in the past decade
Matt's Take By Matthew Herper People are dying from coronavirus because we’re not fast enough at clinical research